Those of you inclined to roll your eyes back into your head

New Post Public Reply Private Reply Replies (3) Message Board
F1ash AlanC #36240
500
Those of you inclined to roll your eyes back into your head and skip reading this post because "ol' F1ash is at it again" need to resist the urge to ignore this post and read to the end. I'm gonna tell you something very important. (At the end). You can skip ahead to the end if necessary.



Ok Alan, I really do hope your doing better and your health is improving.

I don't feel like I am "attacking" you. I gave your theory enough credence to ask management to try the cusip thingy. Why would I do that if I dismissed you offhand?

I have subsequently asked you to at least start including a link to your source when you post the "short volume" percentage. If you haven't noticed I almost alway include links to information I post. Have you noticed that?

You answer so far is basically "No I don't wanna" .

I'm unfortunately left with two reasons I can come up with to explain why you won't include the link.

1. Your shorting (secretly) and want the "daily short" you post to scare people.

I have been assured by people I trust that you are actually long this stock so that leaves me with

Number 2

You want to create the impression that the information is "exclusive" and we need you to provide it. You are indeed important to us and have valuable contributions to make to the board. You can do better than just "the naked shorts are gonna get us all" though in my opinion.

Trying to make it look like that information is "exclusive" to you is akin to plagiarizing imho. It's government data so it's not exactly plagiarism but man it's a close cousin imho.


So that you know ahead of time, if I do convince you to start including the link I'm gonna start in next trying to make you include 5 to 10 other companies percentages each day to make it obvious that the number is unintelligible. Just a heads up of what to expect.

Here comes (the end).

Trials have been 100% successful up until this point and the only possible explanation is the "naked shorts and corrupt MM's" are causing the share price weakness.

Take out a piece of paper and write down your answer to the following question.

Are there unanswered questions in the results from all of the trials so far that could explain the share price weakness because "some uncertainty" still remains?

Well is there?

Yes, there is imho.

I'm about to give you an example. I'm invested here and hope IPIX succeeds so I'm only gonna give you one single example. Since I have an example (I believe) for every single trial for every single indication I'm only going to give you the one that will (I hope) create the least possibility to be used as a tool by shorts. (Make sense?)

Is B-ABSSI a "lock" to succeed?

No, it's not imho and potential partners probably know that. That's why they haven't ponied up a good enough offer just yet. That's also why IPIX is unwilling to "bet the farm" on B-ABSSI. It's not a "lock".

Why do I say that?

Well, because there are still unanswered questions about Brilacidin's effects on Ion channels that are associated with systemic exposure. This could potentially cause cardiac issue limitations.

Horse shit you say?


http://allphasepharma.com/dir/2015/07/10/1693...-juncture/


I have similar DD for every trial thus far imho. (Except Kevetrin which is too complicated for me to tackle). That's not false bravado by the way imho it is just my opinion on the relevance of the DD.

I'm not saying I'm hiding "bad news". I'm just saying there are "unanswered questions" for ever single trial that is probably still affecting the share price and it's not the "naked short bogeyman".

I'm still invested here, even been buying recently so I'm still confident in success and "believe" in management.

This is all just my own opinion about my own DD though so I could be wrong.

I'm not a doctor. Never had a class in microbiology. Not really that smart compared to some of you probably.



I don't see the daily short number as "helpful" I see it as "hurtful" I would ignore it, but it misleads new investors and that's not "right" imho.

Please stop doing it. Please.

On another note, several times daily I have to grit my teeth as I see someone here accusing someone of being someone else or posting veiled threats of personal violence. I hate that and should be deleting it honestly. Please stop.

By the way, if someone accuses me of being someone else I will intentionally reply to posts in "the wrong Id" just to jack with you because I can be a real smart ass myself. It's an occasional hazard.

Have a great day everyone and I'm really hoping for positive Prurisol results.

F1ash

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Steady Income Boosts FHLBank Boston's Growth Q3 2026

Updated Category News Views 50

The Federal Home Loan Bank of Boston dropped their third-quarter results for 2026 like a hot smokestack, and let me tell you, it's a mixed bag of cautious optimism and steady progression. It's essentially proof that slow and steady might just win the race—or at least keep you in the running. Stable and Steady Headway Taking a peek under the hood, FHLBank Boston made a...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 80

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Dimora Medical Boosts Advanced Wound Care at HS Conference

Updated Category News Views 90

Empowering the HS Community with Innovations Look, if you’ve walked a mile in someone else's shoes—particularly ones dealing with hidradenitis suppurativa (HS)—you’d know what a relentless grind managing those exuding wounds can be. Dimora Medical, known for navigating the tricky territory of wound care, threw its hat into the ring at the HS Connect Empower...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 76

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Cowfest 2026 Delighted by Frederick's Flying Cows

Updated Category News Views 40

Moo-ving Towards a New Record Alright, listen up. This fall, there's a bovine spectacle coming to Maryland that's more than just a trip down to the fairgrounds—it's Cowfest 2026, baby! Now, if you're scratching your head thinking this is just another seasonal shindig, you're underestimating what's mooing across Frederick County. The Flying Cows are ready to take the...

Continue Reading
Gemmy's Orchestra of Lights Op. 2 Unveils New Show

Updated Category News Views 6

Jazzing Up the Holidays with Gemmy's Latest Innovation Just when you thought holiday displays couldn't get more extravagant, along comes Gemmy with its latest wonder—the Orchestra of Lights™ Op. 2. Exclusively hitting Lowe's shelves, this isn't your average set of twinkling bulbs. It's an all-out sensory assault, mixing tunes straight out of yuletide hit lists with...

Continue Reading
Hyperliquid Expands Stock Buyback to $100 Million

Updated Category News Views 71

Diving Into Hyperliquid's $100 Million Bold Move Let’s cut through the corporate fluff—Hyperliquid Strategies Inc. just cranked up their stock repurchase program to a cool $100 million. Yep, that’s right—the brain trust behind NASDAQ:PURR has pulled out the checkbook to buy more of its own shares. This decision, unveiled on October 23, 2026, is like tossing a...

Continue Reading
A Game-Changer for Pediatric Diabetes: Novo's Awiqli®

Updated Category News Views 14

Breaking Through the Diabetes Treatment Wall From where I'm sitting, breakthrough approvals like Novo's Awiqli® hit the healthcare landscape with all the subtlety of a freight train. The FDA's green light for Awiqli® as the first once-weekly insulin for kids aged 10 and over with type 2 diabetes is a monumental shift in the treatment paradigm. We're talking about...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 32

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Achievements at the 7th China International Import Expo

Updated Category News Views 143

Successful Conclusion of the 7th China International Import Expo The 7th China International Import Expo (CIIE) has recently concluded, marking a significant milestone in enhancing global trade connections. This remarkable event attracted a multitude of exhibitors and participants from diverse countries, celebrating an array of business opportunities and partnerships. The...

Continue Reading
Pixelworks Invites Shareholders to Revote on Key Proposal

Updated Category News Views 140

Pixelworks Announces Rescheduled Meeting for Shareholders Pixelworks, Inc. (NASDAQ: PXLW), a leader in innovative video and display processing solutions, is reaching out to its valued shareholders regarding the important upcoming Special Meeting. This reconvened meeting represents a crucial opportunity for shareholders to vote on Proposal 1, which aims to authorize the...

Continue Reading
Colombia Reopens Beef Trade with the U.S. Amid Bird Flu Concerns

Updated Category News Views 63

Colombia Rescinds Import Ban on U.S. Beef Amid Bird Flu Concerns Colombia has recently taken a major step by lifting its ban on beef imports from the United States. This decision comes after reports of bird flu found in U.S. dairy cows. A source from the U.S. Department of Agriculture has confirmed that trade can now resume. The Trade Impact of Bird Flu This decision by...

Continue Reading
Anticipating Veru's Earnings: Key Insights for Investors

Updated Category News Views 197

Understanding Veru's Upcoming Earnings Release Veru (NASDAQ: VERU) is preparing to share its quarterly earnings report soon, and anticipation is building among investors. As the company gears up for this announcement, it’s crucial for stakeholders to gather insights on what to expect. Analysts' Expectations for Earnings Projected Earnings Per Share (EPS) Analysts are...

Continue Reading
Veolia Expands Water Technology Strategy for Future Growth

Updated Category News Views 173

Veolia’s Ambitious Growth in Water Technologies Veolia has announced a bold strategy to enhance its role in water technologies, reflecting its commitment to addressing global challenges. With the increasing importance of sustainable resource management, the company is setting its sights on a vibrant market projected to be worth around €220 billion, growing at a rate...

Continue Reading